down arrow

Shandong Jincheng Pharmaceutical Group Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001500
CNY
16.19
-0.64 (-3.8%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shandong Jincheng Pharmaceutical Group Co., Ltd.
Why is Shandong Jincheng Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.32% and Operating profit at 12.06% over the last 5 years
2
With a fall in Net Sales of -11.66%, the company declared Very Negative results in Mar 25
  • OPERATING CASH FLOW(Y) Lowest at CNY 246.97 MM
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,305.57
  • RAW MATERIAL COST(Y) Grown by 18.59% (YoY)
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shandong Jincheng Pharmaceutical Group Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Shandong Jincheng Pharmaceutical Group Co., Ltd.
-100.0%
0.19
58.80%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.32%
EBIT Growth (5y)
12.06%
EBIT to Interest (avg)
10.44
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.75
Tax Ratio
23.63%
Dividend Payout Ratio
77.10%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.19%
ROE (avg)
5.55%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
60
Industry P/E
Price to Book Value
1.87
EV to EBIT
47.11
EV to EBITDA
14.54
EV to Capital Employed
1.92
EV to Sales
2.28
PEG Ratio
NA
Dividend Yield
2.15%
ROCE (Latest)
4.07%
ROE (Latest)
3.09%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-24What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 246.97 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 1,305.57

RAW MATERIAL COST(Y)

Grown by 18.59% (YoY

CASH AND EQV(HY)

Lowest at CNY 1,771.35 MM

NET SALES(Q)

Lowest at CNY 712.67 MM

OPERATING PROFIT(Q)

Lowest at CNY 43.93 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.16 %

NET PROFIT(Q)

At CNY 35.06 MM has Fallen at -28.7%

Here's what is not working for Shandong Jincheng Pharmaceutical Group Co., Ltd.
Net Sales
At CNY 712.67 MM has Fallen at -14.5%
over average net sales of the previous four periods of CNY 833.53 MM
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio
Lowest at 1,305.57
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow
Lowest at CNY 246.97 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Lowest at CNY 712.67 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit
Lowest at CNY 43.93 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 6.16 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit
At CNY 35.06 MM has Fallen at -28.7%
over average net sales of the previous four periods of CNY 49.16 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Cash and Eqv
Lowest at CNY 1,771.35 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 18.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."